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Abstract
Purpose We previously showed that childhood height is
positively associated with prostate cancer risk. It is, how-
ever, unknown whether childhood height exerts its effects
independently of or through adult height. We investigated
whether and to what extent childhood height has a direct
effect on the risk of prostate cancer apart from adult height.
Methods We included 5,871 men with height measured at
ages 7 and 13 years in the Copenhagen School Health
Records Register who also had adult (50–65 years) height
measured in the Danish Diet, Cancer and Health study.
Prostate cancer status was obtained through linkage to the
Danish Cancer Registry. Direct and total effects of child-
hood height on prostate cancer risk were estimated from
Cox regressions.
Results From 1996 to 2012, 429 prostate cancers occur-
red. Child and adult heights were positively and signifi-
cantly associated with prostate cancer risk. When adjusted
for adult height, height at age 7 years was no longer sig-
nificantly associated with the risk of prostate cancer.
Height at 13 years was significantly and positively asso-
ciated with prostate cancer risk even when adult height was
adjusted for; per height z-score the hazard ratio was 1.15
[95 % confidence interval (CI) 1.01–1.32].
Conclusions The effect of height at 13 years on the risk
of prostate cancer was not entirely mediated through adult
height, suggesting that child height and adult height may be
associated with prostate cancer through different pathways.
Keywords Adult  Body height  Child  Cohort studies 
Growth  Prostate neoplasms
Abbreviations
CI Confidence intervals
CSHRR Copenhagen School Health Records Register
DCH Diet, Cancer and Health
HR Hazard ratio
LMS Lambda, Median, Sigma
SD Standard deviation
Introduction
Globally, prostate cancer is the second most frequently
diagnosed cancer, and it accounts for 15 % of all cancers in
men [1]. Despite the frequency, the precise etiological
factors have not been identified. Well-described risk factors
for prostate cancer are limited to age, family history, and
race [1]. Recently, a focus has been placed on adult obesity
as a potential risk factor for prostate cancer [2, 3]. Addi-
tionally, adult height has a consistent, moderate, and pos-
itive association with prostate cancer [3, 4]. Previously, we
showed that taller boys had a significantly increased risk of
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prostate cancer, suggesting that the origins of the adult
association may lie earlier in life [5]. It is, however, not
known whether childhood height and adult height affect
prostate cancer risk through different pathways, or whether
the effect of childhood height is mediated through adult
height. Therefore, the aim of this study was to investigate
whether and to what extent childhood height has a direct
effect on the risk of prostate cancer apart from the effect of
adult height.
Materials and methods
Data sources
Information on height at school ages was obtained from the
Copenhagen School Health Records Register (CSHRR) [6].
The CSHRR is a population-based cohort containing
computerized information on 372,636 children who were
born 1930–1989 and who attended a private or public
school in the Copenhagen municipality. From 2 April 1968
onwards, a unique personal identification number was
assigned to all Danish residents [7]. Children who attended
school in 1968 or later had their identification number
recorded on their health card, while it was retrieved for
children who left school prior to this time.
Information on adult height was obtained by linkage of
children in the CSHRR to the Danish Diet, Cancer and
Health (DCH) cohort [8] via the identification number.
Individuals included in the DCH cohort were enrolled from
December 1993 to May 1997. Inclusion criteria were being
50–64 years of age, born in Denmark, residing in the
Copenhagen or Aarhus areas, and no diagnosis of cancer
registered in the Danish Cancer Registry prior to enroll-
ment. Of 79,728 men who were invited to participate,
27,178 accepted the invitation, filled in a questionnaire,
and were interviewed about their diet and lifestyle [8].
Via the identification number, information on prostate
cancer status was obtained from the Danish Cancer Reg-
istry. It was established in 1942 [9], and the use of multiple
notifications from different data sources secures a high
degree of completeness. Further, through manual quality
controls, validation of information in complex cases, and a
high proportion of morphologically verified tumors, the
validity of information in the register is enhanced [9].
Prostate cancer was defined by the International Classifi-
cation of Diseases 10 code C61. Vital status was obtained
by linkage to the national Vital Statistics Register [7].
Anthropometric information
Childhood height was measured by school doctors or
nurses, and these health examinations were mandatory and
performed annually through 1983 and thereafter only at
school entrance and exit unless the child had specific health
requirements [6]. To account for increases in height during
childhood and across birth years, height measurements
were transformed to z-scores based upon internal sex-, age-,
and birth cohort-specific references (five-year intervals)
using the Lamda, Median, Sigma (LMS) method [10].
Height at age 50–65 years (referred to as adult height)
was measured by a trained laboratory technician [8]. To
facilitate comparisons of the strengths of the associations
across ages despite different standard deviations (SD) for
heights, adult height was transformed to z-scores based
upon internal birth cohort-specific references (1930–1934,
1935–1939, 1940–1944, 1945–1947). Adult height was as
childhood height normally distributed, and the z-scores
were calculated as standard z-score = [(observed
value - population mean)/SD] using all information
available among DCH males identified in the CSHRR.
Study population
The starting population for this study was men included in
the CSHRR with an identification number, who were born
1930–1947, and who did not die, emigrate, or become lost
to follow-up before 1 May 1993 or age 50 years (entry date
and age criteria in the DCH cohort). In the eligible popu-
lation of 6797 men included in both the CSHRR and the
DCH, 62 were excluded due to a diagnosis of any cancer
prior to enrollment in the DCH study, seven men with
missing information on adult height, and 857 without
information on height either at 7 or 13 years of age were
excluded. Follow-up started on December 1993 through
May 1997 at ages 50–65 years, upon enrollment into the
DCH study, and ended at the date of diagnosis of prostate
cancer, death, emigration, loss to follow-up, or 31
December 2012, whichever came first.
Ethics
The project was approved by the Danish Data Protection
Agency. According to Danish law, ethical approval is not
required for purely register-based studies.
Statistical analyses
Anthropometric characteristics (mean, SD, and median)
were calculated for the included men. Correlation analyses
between height at ages 7 and 13 years and adult height
were performed, and the number of cases and incidence
rate of prostate cancer were calculated in categories of
height at each age.
Cox proportional hazards regression was used to
examine associations between height z-scores and the risk
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of prostate cancer. Age was used as the underlying time-
scale, and the baseline hazard was stratified by birth cohort
(1930–1934, 1935–1939, 1940–1944, 1945–1947).
We examined associations between height z-scores at
the ages of 7 and 13 years and in adulthood with prostate
cancer, individually. Next, we examined the associations
between height z-scores at ages 7 and 13 years, respec-
tively, and prostate cancer with adjustment for adult height.
Finally, associations between adult height z-score and the
risk of prostate cancer were examined with adjustment for
childhood heights.
The proportion of the risk of prostate cancer associated
with childhood height mediated through adult height was
estimated by the difference in coefficient method on the log
hazard ratio (HR) scale, i.e., mediated proportion =
(log(HRchild) - log(HRchild?adult))/log(HRchild) * 100 [11,
12]. Confidence intervals (CIs) for the mediated proportion
were computed by nonparametric bootstrapping (i.e., ran-
dom sampling with replacement from the original sample)
using 5,000 replications each time computing the implied
value for the mediated proportion.
The effect of change in height during childhood was
examined in a model including height z-scores at both 7
and 13 years, with and without adjustment for adult
height z-score. Potential interactions between height z-
scores at ages 7 and 13 years, respectively, and adult
height z-score as a categorical variable (\-0.68, -0.68 to
0.68 [reference], [0.68) on the risk of prostate cancer
were investigated based on the likelihood ratio test. None
of these tests were statistically significant (range for
p values 0.67–0.99).
The linearity of the associations in all models was
assessed by testing against a restricted cubic spline with
four knots [13]. Potential interactions between height
z-scores and year of birth (1930–1934, 1935–1939,
1940–1947) were tested using a likelihood ratio test in
nested models with and without cross-product terms. The
proportional hazards assumption underlying the Cox
models was investigated by including a term in the model
that allowed the effect of the height z-score to change with
age at risk and testing whether the change in the HRs was
significant. Significant deviations from linearity, modifi-
cation by birth cohort, or violations of the proportional
hazards assumption were not observed (not shown).
Results
In total, 5,871 men were included in the study. During
88,559 person-years of follow-up (mean = 15.1 years,
range 0.2–19.1 years), 429 (7.3 %) prostate cancer diag-
noses were recorded from 1996 through 2012 at the ages of
54.6–81.3 years. Of these, 112 died during follow-up.
Mean height in childhood and adulthood increased by birth
cohort (Table 1).
As expected, height at ages 7 and 13 years and adult
height were all strongly and positively correlated. The
correlation between height at 7 years and adult height
(r = 0.77) was slightly stronger than between height at
13 years and adult height (r = 0.70). The strongest corre-
lation was between height at 7 and 13 years (r = 0.87).
The incidence rate of prostate cancer increased across
categories of height at age 7 and 13 years and in adulthood
(Table 2). We detected positive and significant associations
of similar size between height at ages 7 and 13 years,
respectively, and the risk of prostate cancer (Table 3).
Height in adulthood was also associated with a signifi-
cantly increased risk of prostate cancer (Table 3). Although
the height z-scores are birth cohort-specific, moving from a
z-score of 0 to a z-score of 1 corresponds to *5.0 cm at
7 years, *7.3 cm at 13 years, and *6.5 cm in adulthood
(Table 1).
When adjusted for adult height, height at age 7 years
was no longer significantly associated with the risk of
prostate cancer. In contrast, the association between height
at age 13 years and the risk of prostate cancer was only
minimally influenced, and it remained significant even
after adjustment for adult height (Table 3). Adjustment for
childhood height, in particular height at 13 years, attenu-
ated the association between adult height and prostate
cancer, which in these models represent change in height
from childhood to adulthood, and it became nonsignificant
(Table 3).
Table 1 Height by age of measurement and by birth cohort among
boys from the Copenhagen School Health Records Register who
participated in the Danish Diet, Cancer and Health study as adults
Age (years) Birth cohort N Height (cm)
Mean SD Median
7 1930–1934 1,035 120.6 5.0 120.5
1935–1939 1,779 121.0 5.1 120.9
1940–1944 2,584 121.9 5.0 121.9
1945–1947 473 123.0 5.0 123.2
13 1930–1934 1,035 150.4 7.1 150.0
1935–1939 1,779 152.1 7.2 151.9
1940–1944 2,584 153.1 7.4 152.9
1945–1947 473 153.9 7.5 153.6
50–65 (adult) 1930–1934 1,035 175.3 6.3 175
1935–1939 1,779 176.4 6.6 176
1940–1944 2,584 177.0 6.5 177
1945–1947 473 178.1 6.2 178
cm centimeters, SD standard deviation
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Of the total effect of height at 7 years, the estimated
proportion mediated through adult height was 38.5 %
(95 % CI -50.1 to 201.3); the wide CI indicates that
anywhere from 0 to 100 % is mediated through adult
height. The estimated mediated proportion of height at
13 years was 15.6 % (95 % CI -43.4 to 93.7) of the total
effect; the wide CI indicates that anywhere from 0 % to a
large proportion is mediated through adult height.
The effect of change in height from 7 to 13 years of age
on the risk of prostate cancer was examined by including
both height measurements in the same model. Height at
13 years, conditioned on initial height at age 7 years,
which represents excess growth from 7 to 13 years of age,
was positively and borderline significantly associated with
prostate cancer risk (HR13years = 1.20, 95 % CI 1.00–1.46)
(Table 3). When we additionally included adult height in
this model, the association with height at 13 years, condi-
tional on both height at 7 and adult height, remained of the
same strength as compared to the models including height
at each age separately or height at both 7 and 13 years
(Table 3). The estimate for height at 13 years, conditional
on heights at 7 years and in adulthood, represents the
timing of growth as it compares men with different heights
at 13 years but who had the same heights at age 7 years
and as adults.
Discussion
We found positive and significant associations between
childhood and adult height, respectively, and the risk of
prostate cancer. Interestingly, we found that height at
13 years remained significantly and positively associated
with the risk of prostate cancer independently of adjust-
ment for adult height meaning that the association between
height at 13 years and the risk of prostate cancer was not
entirely mediated through adult height. Our results there-
fore indicate that being tall at 13 years of age, at least to
some extent, increases the risk of prostate cancer inde-
pendently of attained adult height.
Table 2 Number of cases and incidence rate of prostate cancer by categories of height z-scores at ages 7 and 13 years and in adulthood
Age (years) Category of height
z-score
Cm equivalenta Frequency
(%)
Cases
(n)
Person-years of
follow-up
Incidence rate
per 1,000
7 -4.5 to -0.68 102.6–119.2 25.12 87 22,538 3.86
-0.68 to 0.68 116.9–126.2 50.79 230 44,781 5.14
0.68 to 4.5 124.0–138.1 24.08 112 21,240 5.27
13 -4.5 to -0.68 127.8–148.5 24.34 80 21,795 3.67
-0.68 to 0.68 145.0–158.9 50.55 222 44,651 4.97
0.68 to 4.5 154.7–179.4 25.11 127 22,113 5.74
50–65 (adult) -4.5 to -0.68 154.0–173.5 24.37 88 21,386 4.11
-0.68 to 0.68 171.5–182.0 50.77 220 45,277 4.86
0.68 to 4.5 180.0–199.0 24.85 121 21,895 5.53
a The range of heights across categories is slightly overlapping, because the range is presented across birth cohorts, and z-scores were calculated
separately for each birth cohort
Table 3 Hazard ratios of
prostate cancer risk in adulthood
per height z-score at age 7 and
13 years and in adulthood,
unadjusted and adjusted for
height z-scores at the ages
included at the present row
(n = 5,871, 429 cases)
Ages in model Height z-score
7 years 13 years 50–65 years
HR 95 % CI HR 95 % CI HR 95 % CI
7 years 1.15 1.04–1.27 – – – –
13 years – – 1.18 1.07–1.30 – –
Adult – – – – 1.14 1.04–1.26
7 and 13 years 0.98 0.81–1.18 1.20 1.00–1.46 – –
7 years and adult 1.09 0.94–1.27 – – 1.07 0.93–1.24
13 years and adult – – 1.15 1.01–1.32 1.04 0.91–1.18
7 and 13 years and adult 0.94 0.76–1.17 1.20 0.99–1.45 1.06 0.91–1.23
HR hazard ratio, CI confidence interval
All analyses are stratified by birth cohort (1930–1934, 1935–1939, 1940–1944, 1945–1947)
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Height at 13 years may be a biological marker for an
increased level of insulin-like growth factor 1, which is
especially high during puberty [14] and is associated with
an increased risk of prostate cancer [15]. It is, however,
also possible that height at 13 years is an indicator for a
risk established by an unmeasured third factor that operated
earlier in life and increases height during this late part of
childhood as well as the risk of prostate cancer. This may
explain why height at 13 years was not entirely mediated
through adult height and hence seems to affect prostate
cancer risk through different pathways than adult height.
From the results of the present study, we cannot conclude
whether the effect of height at 7 years is due to a direct
effect or whether it is mediated by adult height.
In the model including height at 7 and 13 years, height
z-score at 13 years estimates the effect of a greater growth
in height from 7 to 13 years. The results indicated that
growth from 7 to 13 years of age was more important than
height at 7 years conditional on height at 13 years for the
risk of prostate cancer. When heights at 7 years, at
13 years, and in adulthood were all in the same model, only
the estimate for height at 13 years remained positive and
significant. The interpretation of this estimate is that a child
who had an ‘‘average’’ height at 7 years and in adulthood,
but was tall at 13 years, has an increased risk of prostate
cancer compared to a child who had an ‘‘average’’ height at
all three points in time.
The correlations between height at 7 years and adult
height (r = 0.77) were broadly similar, albeit slightly
stronger than at age 13 years (r = 0.70). A possible
explanation for this may be that age at peak height velocity
affects the correlation between height at 13 years and adult
height. In a study of the 1958 British birth cohort, corre-
lations among boys between height at ages 7, 11, and
16 years, respectively, and age 33 years were r = 0.70,
r = 0.72, and r = 0.77 [16]. The slight differences
between these correlations and those from the current study
may be explained by the different ages at measurement or
random error.
Two previous studies investigated the association
between childhood height and risk of prostate cancer. One
small study including 33 prostate cancer cases reported an
odds ratio of 1.10 (95 % CI 0.80–1.51) [17] for height at
age 2–14 years. In our previous study including 3,355
cases among men from the CSHRR, the HR was 1.13
(95 % CI 1.09–1.17) [18] per height z-score at 13 years.
Thus, the results in the present study on a subsample of the
CSHRR and our previous study are largely consistent.
Additionally, numerous studies have reported a positive
association between adult height and the risk of prostate
cancer [3, 19–24]. A meta-analysis including 31 cohort
studies reported an odds ratio of 1.09 (95 % CI 1.06–1.12)
for the risk of prostate cancer per 10-cm increment in
height [4], which is very similar to the effect of adult height
in the current study (HR 1.14, 95 % CI 1.04–1.26).
We did not identify other studies that reported on
associations among childhood height, adult height, or other
potential mediators and prostate cancer. Consideration of
other potential mediating pathways is compromised by the
limited knowledge of the origins of prostate cancer. Evi-
dence is emerging that metabolic risk factors in adulthood
are associated with the risk of prostate cancer, but results
are inconsistent [21, 24, 25]. Therefore, mediation of the
effect of childhood height through metabolic factors is
likely of low importance. It remains a possibility that
childhood height is not mediated by measurable factors
expressing their effects on prostate cancer in adulthood, but
leaves a permanent effect that is initiated already during
childhood.
In this study, we are examining incident prostate cancer
rather than mortality or survival. The distinction is
important as many forms of prostate cancer are indolent
and unlikely to progress to death. Adult height is particu-
larly associated with aggressive and fatal forms of prostate
cancer [4, 26, 27]. In a previous study, we found that
childhood height was positively associated with both
prostate cancer death and survival [28]. Due to the low
number of prostate cancer deaths in this population, we
were unable to examine survival in this study.
The major strength of this study is the combination of
data sources providing information on measured height all
the way from childhood to adulthood in an ethnically
homogeneous population combined with the long-term
follow-up in the Danish Cancer Registry. As heights were
measured both in childhood and adulthood, they are not
subject to recall bias. Any misclassification from these
measurements is most likely nondifferential, potentially
leading to bias toward the null.
The study limitations include the relatively small num-
ber of cases, and that information on possible childhood
height determinants, such as parental socioeconomic
position, genetics, dietary status, and onset of puberty, was
not available [14, 15]. Further, as Gleason score informa-
tion was not electronically available, we were unable to
examine associations between height and the prostate
cancer aggressiveness. As for puberty assessment, no sin-
gle measure exists for the onset of puberty in boys that can
be ascertained with reasonable accuracy of recall [14]. The
participation rate in the DCH cohort was 34 %, and the
participants had a higher socioeconomic position than
nonparticipants [8]. Attrition in the present study resulted
mainly from a lack of identification of DCH participants in
the CSHRR, which was dependent on schooling in
Copenhagen. Thus, the generalizability of our results may
be reduced. In addition, the included study sample was
slightly taller (0.0–0.5 cm across birth cohorts and ages)
Cancer Causes Control (2016) 27:561–567 565
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than all boys from the CSHRR born in the years
1930–1947. Therefore, a follow-up selection bias cannot be
excluded. Our findings need to be confirmed in larger
samples and in other settings of other ethnicities.
In conclusion, we found that height at 7 years of age
increased the risk of prostate cancer only before adjustment
for height at 13 years and/or adult height. In contrast,
height at 13 years of age had a significant and positive
association with the risk of prostate cancer that was not
entirely mediated through adult height or dependent on
height at 7 years. This means that being tall at 13 years of
age increased the risk of prostate cancer independently of
attained adult height and that height at 13 years is not just a
proxy for final height. Until more evidence on the origins
of prostate cancer is available, the present results encour-
age a search for determinants of adolescent height that
create the pathway to prostate cancer.
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